• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
  • Measuring and Valuing Outcomes

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

PROMS_unsplash_National Cancer Institute_landscape
Read more
© NCI/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 11th October 2016

Contract Theory: Nobel Offerings to Health Economics

The Nobel in Economics was awarded to Oliver Hart and Bengt Holmström for their research on Contract Theory. This blog reviews the contributions of contract theory to health economic issues. The 2016 Sveriges Riksbank Prize in Economic Sciences in Memory…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

The Nobel in Economics was awarded to Oliver Hart and Bengt Holmström for their research on Contract Theory. This blog reviews the contributions of contract theory to health economic issues.

The 2016 Sveriges Riksbank Prize in Economic Sciences in Memory of Alfred Nobel (commonly referred to as the Nobel Prize in Economics) has been awarded to Oliver Hart and Bengt Holmström for their contribution to Contract Theory. In the words of the Royal Swedish Academy of Sciences, “Oliver Hart’s and Bengt Holmström’s research sheds light on how contracts help us deal with conflicting interests”.

Economic transactions between self-interested economic agents (i.e. buyer-seller, worker-employer, lender-borrower, government-tax payers) can give rise to conflicts of interests. Contracts help to avoid economic losses and undesirable social outcomes by generating trustworthiness and enforcing cooperativeness between agents. Contract theory attempts to understand the nature of contracts and how they should be designed to achieve optimal and socially desirable outcomes, especially under conditions of uncertainty and asymmetric information. Contract theory has made significant contributions to the study of insurance, incentives, information and economic institutions. Within health economics, contract theory has guided policies aimed at improving health care systems’ performance. Contract theory is relevant to the implementation of co-payments in a health care system, how we incentivise health care providers, pricing agreements between health care systems and pharmaceutical firms, and the public-private health care provision debate.

Bengt Holmström in Moral Hazard and Observability demonstrated that rewards and punishments must be linked to those outcomes that can be influenced by the actions of relevant agents in order to avoid luck playing a role. This is the informativeness principle which means that incentives in optimal contracts must be linked to those outcomes that are informative about agents’ observable actions. Following the informativeness principle co-payments should be implemented for those health care goods and/or services whose demand is closely related to and a consequence of patients’ behaviour.

Contract theory is also relevant for the design of incentives for health care providers. Providers are agents of both patients and the health care system (principals), and they are potentially conflicted in terms of the care they provide due to a problem known as the principal-agent relationship. The Quality and Outcomes Framework (QOF) within the NHS is a good example of how the informativeness principle can work in relation to health care provision. The QOF rewards practices for providing ‘quality of care’ and helps to fund further improvements in health care (for example see Feng et al., 2014).

A defining feature of Oliver Hart’s contribution was the theory of incomplete contracts. Given contracts cannot specify every eventuality, Hart and his colleagues posited that it can be helpful to agree now to agree later. An example of incomplete contracts in health economics is Performance Based Risk-Sharing Agreements (PBRSAs) where pharmaceutical firms negotiate higher prices for those drugs that demonstrate higher value or less uncertainty ex post. When the value of a new medicine is difficult to ascertain ex ante at the initial contracting point between a payer and pharmaceutical company, an alternative is to track the performance of the product in a defined patient population over a defined time period, so that reimbursement is based on the health and cost outcomes achieved (Garrison, Towse et al., 2013). PBRSAs represent a mechanism for reducing uncertainty at product launch and incentivising investment in evidence collection while a technology is used within a health care system.

Incomplete contract theory can also be applied to the debate on public versus private health care provision. Should health care provision be privatised? Incomplete contract theory showed that this depends on the nature of non-contractible investments such as cost-reduction or quality improving investments. Hart and colleagues, in their article The Proper Scope of Government: Theory and an Application to Prisons, demonstrated that if incentives for cost reduction are strong then the privatisation of public sectors may be undesirable. This is because focusing on cost reduction alone may hurt the quality of the goods and services provided.

The examples outlined above highlight some of the contributions that contract theory has made to health economics. As a result of Oliver Hart and Bengt Holmström’s research we can improve the optimal design of contracts, such that health care systems can maximise efficiency and social welfare.

  • Healthcare Systems
  • Pricing and Reimbursement

Related News

  • News
  • September 2020

Cornerstones of ‘Fair’ Drug Coverage

Read more
  • News
  • September 2020

Establishing a Reasonable Price for an Orphan Drug

Read more
  • News
  • June 2020

The 2020 OHE Annual Lecture Explores the Question: How Should the World Pay for a COVID-19 Vaccine?

Read more
Danzon_Patricia_1305 (1)
  • News
  • June 2020

Victor R. Fuchs Award for 2020 Goes to Patricia Danzon

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!